Toolless Change Parts: A Flexible Solution
Aseptic fill-finish professionals are continually looking to augment their approach to a market that continues to grow and reflect innovations happening around sterile parenteral treatments. When considering the flexibility of an operation, it’s important to investigate every aspect of the fill-finish process. Flexibility applies to any process or technical optimization that quickens scalability and removes […]
AST at Virtual Pharma Expo 2023
Josh Russell gives a live demonstration of AST’s isolated GENiSYS C as part of Virtual Pharma Expo 2023.
Point of Contact: The Importance of an Intuitive HMI
As aseptic fill-finish technology continues to make strides towards broader use of robotics and automation, the usability and performance of a system’s Human Machine Interface (HMI) becomes vital to the operator. Considering the amount of complexity native to aseptic processing and the variables possible in any given system, including format, finishing, and barrier options, fill-finish […]
AST Perspectives: Looking Towards a Fill-Finish Future Rooted in American Ingenuity
A Word from AST President & CEO Joe Hoff It’s common practice at AST to revisit our Mission Statement as we go about our work to provide quality fill-finish solutions to our customers. That mission—to enhance the reliability, productivity and safety of aseptic processing by offering intelligent, intuitive, and innovative solutions—informs every aspect of what […]
Ready and Sealed: The RTU Advantage for Optimal Vial Sealing
For small-batch, high-value drug products, the aseptic advantages of pre-sterilized ready-to-use vials are clear. To realize the full scope of benefits that RTU vials can provide, integration with traditional processes and equipment must be carefully considered. Modern and flexible technologies such as robotics are key to seamlessly integrating RTU vials into aseptic fill/finish processes. The […]
Technology Transfer Strategies: Fill-Finish Automation and Robotics
Throughout the lifecycle of a drug product, many critical target points for optimization make all the difference in the time-to-market equation. A holistic approach to the drug development process that’s able to anticipate challenges in production, regulatory requirements, and manufacturing practices should be considered. A key component of this approach is establishing early and clear […]
Preparing for the Small Batch Revolution: Identifying Successful Biopharmaceutical Partnerships
Small-batch manufacturing of liquid pharmaceuticals is slated for exponential growth in the coming years and represents exciting possibilities for the future of medicine and personalized healthcare. Whether biologics, biosimilars, or orphan drugs developed in the fight against rare diseases, technology is providing solutions for the manufacturing challenges traditionally associated with small-batch aseptic processing and consequently […]
Germfree Laboratories and AST Unite to Redefine Aseptic Fill-Finish Processing Technology
Revolutionary Collaboration to Introduce an American-Made Turn-Key Solution with Unparalleled Innovation Ormond Beach, Florida, and Tacoma, Washington, 09-October-2023 — Germfree Laboratories, a global leader in isolator technology for aseptic processing and containment in the pharmaceutical sector, and AST, a pioneer in aseptic fill-finish processing technology, are thrilled to announce a revolutionary partnership. This landmark collaboration […]
Fill-Finish for Biosimilars: Ready, Set, Develop!
The last four years have seen remarkable developments in the field of cell and gene therapy. In 2019, the FDA forecasted that the US is likely to add 10-20 cell and gene therapies per year until 2025, and current prognostication has development tracking at that speed.
503 Pharmacies: Integral Partners in the Healthcare Industry
The last four years have seen remarkable developments in the field of cell and gene therapy. In 2019, the FDA forecasted that the US is likely to add 10-20 cell and gene therapies per year until 2025, and current prognostication has development tracking at that speed.